This project was supported by Frost & Sullivan. Amanda Weaver provided expert editorial assistance.
1. Kelso P. We've no idea how big the problem is. Guardian Unlimited. 2003;http://sport.guardian.co.uk/athletics/story/0,10082,1070015,00.html.
2. Dickinson M. FA to alter drugs rules after trying Ferdinand. Times online, 2003;http://www.timesonline.co.uk/article/0,,277-873357,00.html.
4. Frost & Sullivan. European Drugs of Abuse Testing: Non-Healthcare Markets. 2003; www.frost.com.
5. Independent Inquiry into Drug Testing at Work. Final Topline Results. 2003;http: //www.drugscope.org.uk/uploads/goodpractice/documents/MORI%20%20top%2oli ne%results.pdf.
6. Moeller M, Steinmeyer S, and Aberl F. Operational, User and Legal Requirements across EU Member States for Roadside Drug Testing Equipment. 1999; ROSITA Contract DG VII PL98-3032.
7. Verstraete A and Puddu M. General Conclusions and Recommendations, Deliverable D5 of the ROSITA Project. 2000;www.R0SITA.org.
8. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2003: the state of the drugs problem in the European Union and Norway. 2003;http: //annualreport.emcdda.eu.int/en/home-en.html
9. De Gier JJ. Drugs other than alcohol and driving in the European Union. Institute for Human Psychopharmacology, University of Limburg, Maastricht, The Netherlands, Tech Report IHP 95-54, 1995.
10. British Medical Association. Driving Under the Influence of Drugs, 2003.
11. Wong A. (2003). Trends in point-of-care testing for drugs of abuse. European Clinical Laboratory 2003;22:12--14.
12. Wong A. (2003). Boosting the drug abuse testing market. Global Discovery & Development 2004; pp. 6-7.
Was this article helpful?